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Urine stone risk factors in nephrolithiasis patients with and [11, 12]. However, given bowel surgery, rates are about
without bowel disease. two- to threefold higher within each study, giving a stone
Background. The prevalence of nephrolithiasis among pa- prevalence of 3.7 to 16% for all surgeries combined [2, 8].tients with bowel disease is higher than in the general popula-
Much has been inferred concerning the reasons fortion. We examined urine stone risk factors and clinical charac-
teristics of these patients, contrasted with a large group of stone stones among bowel disease patients, especially those who
forming patients without systemic disease. have had surgery. Urine volumes and pH values are gen-
Methods. A total of 180 patients with bowel disease were erally below those of normal people [9, 13, 14], whereascompared with a group of 2048 nephrolithiasis patients with
urine oxalate excretion rates are relatively high when acalcium or uric acid stones and without systemic diseases. Bowel
diseases included inflammatory bowel disease with and without functioning colon is present [15–17]. Urine calcium ex-
bowel resections, bowel resections from cancer or trauma, and cretion is generally normal [13, 17], except among those
bypass procedures for obesity or hypercholesterolemia. Urine who have had small bowel resection. Their urine calciumstone risk factors, stone rates, stone compositions, and creati-
is low [13, 18]. All of these departures from normal sub-nine clearance were measured.
jects suggest reasons for stone formation among patientsResults. Compared to ordinary stone forming patients, bowel
patients formed stones higher in rate of recurrence and in uric with bowel disease. However, by their very nature, the
acid content. Uric acid content was highest when colon surgery studies themselves could not be definitive.
had occurred. Urine volumes were low among all bowel patients
One problem with all past studies is that stone formingexcept those with a bypass. Average creatinine clearance values
patients with bowel disease have never been comparedwere low among all bowel patients. Urine oxalate excretion was
modestly elevated after small bowel resection, but very high to a large population of stone forming patients from
with bypass. Supersaturations were increased mainly by low which such bowel diseases have been explicitly excluded.
urine volume and—for uric acid—low pH. Patients with no
Comparisons have generally been made with populationssurgery were indistinguishable from routine stone formers.
of normal people. Another problem is that stone riskConclusions. Low urine volume and pH are the main stone-
forming abnormalities in bowel disease patients. Hyperoxaluria factors have often been presented among bowel disease
is extreme after bypass, but only modest after small bowel sur- patients who have not, in fact, necessarily formed stones.
gery. In the absence of surgery, bowel disease patients with
Put another way, if one is concerned with stone formingstones cannot be distinguished from common stone formers
patients and wants to understand the effects of bowelby comprehensive stone risk measurements.
disease, a comparison between two groups of stone for-
mers is necessary: one with and one without bowel dis-
ease. In addition, bowel disease can be complicated by aThe prevalence of nephrolithiasis among patients with
bowel disease is higher than in the general population variety of surgical interventions that include colon resec-
[1–7]. Among those patients who have not had bowel sur- tion, small bowel resection, or both, or no surgery may
gery, the prevalence of stones has ranged from 1.5 to have been done. Stone risk factors among actual stone
5% [2, 8–10], which is not different from the usual val- formers within each of these groups to our knowledge
ues for United States stone prevalence rates (3 to 5%) have never been detailed.
We present here comprehensive panels of stone risk
factors for all of these groups, and compare them to aKey words: nephrolithiasis, bowel disease, bypass, obesity, hyperoxal-
uria, calcium stones, uric acid stones. large population of stone forming patients who have no
bowel disease at all. Finally, bowel disease may be ac-
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METHODS Analysis of data
Given the purposes of this study, patients were groupedPatients
according to surgical interventions: bowel disease with-From a total of 3511 patients with nephrolithiasis (2313
out surgery, colon resection, small bowel resection, both,men, 1198 women), who have entered our program be-
and bypass surgery.ginning October 1969 and extending to the present, we
Stone recurrence rates were calculated as the totalselected 180 patients who represent all of those with
number of new stones, divided by the interval betweenorganic bowel disease. These are referred to as “bowel
the first stone and the date of entry into our program. Thepatients.” The diseases they had include inflammatory
first stone is included. This is our conventional methodbowel disease with or without bowel resection, bowel re-
[20]. Stone rates were not normally distributed (Fig. 1A)sections for other causes such as cancer or trauma, and
for either the bowel cases (top) or the stone rate refer-bowel bypass procedures for treatment of obesity or
ence group (bottom). Log transformed rates are linearhypercholesterolemia. All had been evaluated using a
versus a normal distribution function (Fig. 1B). For theclinical and laboratory protocol described elsewhere
bowel cases (top) Kolmogrov-Smirnov Lilliefors proba-[19, 20]. Briefly, three 24-hour urine collections were
bility values were 0.955 and0.00001 for log transformedobtained prior to treatment, with corresponding blood
versus untransformed distributions. For the 1688 stone
samples drawn between 7 and 9 am in the post-absorptive
rate reference group patients, P values were0.00001 for
state. A complete clinical history was obtained that in-
both groups, although the maximal difference between
cluded reviews of all available medical records, radio- the distribution of standardized stone rates and the nor-
graphs, and stone analyses. Dates of disease onset for mal probability function (maximum difference  0.046)
bowel disease or bypass surgery, or surgery that pro- was not remarkably different from the maximal differ-
duced short bowel in patients with cancer or trauma, ence for the bowel disease patients (0.033). In part, this
were obtained from our records. Since all urine studies latter reflects the obvious deviation from linearity in
reported here were obtained prior to the initiation of Figure 1B (bottom) and in part the very large sample
stone prevention treatment, no patient was on such treat- size for the reference group. Despite less than perfect
ment during these collections. The results therefore re- normality in the log transformed reference group, we
flect the effects of their bowel disease and whatever med- have used log (10) transformed stone rates to calculate
ications the bowel disease itself required, but no effects means, SEM, and to perform comparisons.
of measures directed against stone formation. For each patient, average 24-hour creatinine clearance,
For contrast, we have employed 2048 calcium or uric supersaturations with respect to calcium oxalate, calcium
acid stone-forming patients who have no bowel disease phosphate, or uric acid, and urine excretion rates of uric
nor any other relevant systemic disease causing stone: acid, calcium, oxalate, citrate, urine pH, and urine vol-
for example, primary hyperparathyroidism, sarcoidosis, ume were calculated so that each patient, bowel disease
laxative abuse, and all other such [21]. They are referred and reference, occupies a row. Twenty-four-hour creati-
to as the “risk factor reference patients.” Their mean age nine clearance was calculated conventionally for each of
at the time of our study was 44  1 years. A subset of the three pre-treatment 24-hour urine samples and corre-
1688 patients from this group was used for calculation sponding blood sample. Univariate statistics and t tests,
of stone formation rates, and was referred in this study and quantile plots were performed within patient groups,
as the “stone rate reference patients.” This subset was with each patient, therefore, represented by one average
selected because there were complete data concerning value for all variables concerned. Analysis of variance
dates and numbers of recurrent stones for this group. (ANOVA) with the surgical grouping of patients as the
factor was used for comparing stone risk factors between
Evaluation protocol and among groups. Post-hoc testing used the Bonferroni
Measurements in all urines included volume, pH, cal- correction for multiple comparisons. Multivariate linear
cium, phosphorus, citrate, oxalate, magnesium, potassium, modeling was used to determine independent correlates
sodium, ammonium, sulfate, uric acid, and creatinine. of supersaturation, as required. Statistics were calculated
In serum, creatinine, calcium, magnesium, phosphorus, using standard statistical software (Systat, Chicago, IL,
sodium, potassium, uric acid, chloride, and total CO2 USA).
content were measured. Analytical methods are detailed
elsewhere [19]. Supersaturations were calculated for cal-
RESULTScium oxalate monohydrate, uric acid, and calcium phos-
Characteristics of patients and their stonesphate—as brushite (calcium monohydrogen phosphate)—
using the EQUIL 2 program [22]. All patients, bowel and Of the 180 bowel patients 140 (77%) were men (Ta-
ble 1). A majority had inflammatory bowel disease. Bowelreference, were evaluated in the same manner.
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Fig. 1. Distributions of stone rates. Untrans-
formed stone rates (x-axes, A) for bowel pa-
tients (top) and the stone rate reference pa-
tients (bottom) were not normally distributed
as shown by lack of linearity when plotted
against a normal distribution function (y-axes).
When log transformed (B), rates were reason-
ably linear, indicating a fit to the normal distri-
bution function. For bowel patients, deviation
from normality was not significant (Kolmo-
grov-Smirnov Lilliefors, P0.95). For the much
larger stone rate reference population, devia-
tion was significant (P 0.00001) although the
maximal difference (0.046) was not remark-
ably different from the maximal difference for
the bowel disease patients (0.033).
Table 1. Surgical intervention versus etiology of bowel disease
Type of surgery
Etiology Bypassa Bothb Colon only Small only None All
IBD — 22 (20) 44 (37) 30 (23) 30 (27) 126 (107)
Other — 7 (4) 14 (9) 6 (3) — 27 (16)
Total 27 (17) 29 (24) 58 (46) 36 (26) 30 (27) 180 (140)
Age bowel Dx 372c 252 342d 242 272 301
Abbreviations are: IBD, inflammatory bowel disease, including ulcerative colitis and Crohn’s disease; others include bowel resections for cancer, trauma, surgical
accidents. Cells that cannot logically exist are marked by a dash. Bypass is both a surgery and an etiology. Men are shown in parentheses. Mean age for “All” was
not tested against any groups and is shown for reference.
a Bypass included 25 for obesity, 2 for hypercholesterolemia
b Small and large bowel surgery
c Differs from both and small only, P  0.03
d Differs from small only, P  0.02
patients were divided into five groups (Table 1): those between the groups by ANOVA (P  0.002). Specific
differences were present between the Bypass versus Bothwith bypass surgery (Bypass); both colon and small
bowel surgery (Both); colon only surgery (Colon Only); and Small Only groups (P  0.007 and 0.049, respec-
tively), and between the Colon Only versus Both groupsmall bowel only surgery (Small Only); and no surgery
(None). The sexes are represented equivalently among (P  0.044). For the entire cohort, the mean time be-
tween diagnosis of bowel disease and onset of stonesthe groups (2  7.14, DF  4, P  0.127). Age of bowel
disease onset was older for Bypass and Colon Only pa- was 7.68 years (95% CI  6.0–9.3 years, P  0.0001 vs.
0). For each of the surgical subgroups the interval wastients. On average, patients began forming stones after
the diagnosis of bowel disease, and only a small fraction positive and differed from zero with a P 0.01. Of note,
among patients with no surgery the mean was 6.8 (95%(Fig. 2B) formed stones prior to diagnosis. The interval
from diagnosis (Table 1) to first stone (Fig. 2) differed CI  2.4–11.2 years, P  0.004 vs. 0).
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Fig. 2. (A) Percent calcium oxalate () in stones formed by patients, none of whose stones contained any uric acid, and percent uric acid () in
stones formed by patients any of whose stones contained uric acid. For the no uric acid groups (), the remainder of the stones is comprised of
calcium phosphate. The five groups are distributed along the y-axis. Differences in frequency and percent uric acid are in the Results section. (B)
Time (years) between the diagnosis of bowel disease and formation of first stone (x-axis) versus bowel disease patient group (y-axis). Positive
values indicate that stone formation began after diagnosis of bowel disease. Symbols are: () means  SEM; () individual patients. Groups are
defined in the Methods section: Bypass (6  2) differed from Both (13  2) and Small Only (11  1). Colon Only (6  1) differed from Both.
Patients with no surgery (6  2) differed from no other group (P values are in the text).
Stone analyses were available for 133 of the 180 bowel other groups in percent uric acid (P  0.02, all compari-
sons). Calcium phosphate percent contributed far less topatients, and 1156 of the 2048 risk factor reference pa-
tients (74%). Bowel patients whose stones contained stones formed by the bowel patients than the risk factor
reference patients (6  2 vs. 17  1, bowel patientsno uric acid on any occasion formed stones that were
predominantly calcium oxalate (Fig. 2A). The bowel dis- vs. reference, P  0.0001). The overall percent calcium
oxalate in stones did not differ between bowel patientsease patients differed from the risk factor reference pa-
tients in the frequency of any uric acid in stones (2  and reference patients (75 vs. 75%). Stated more gener-
ally, uric acid occurred in stones of bowel disease patients19.86, P 0.00001). When uric acid was present in stones,
it was usually the predominant phase (Fig. 2A). Among at a higher rate and a higher fractional percent than in
risk factor reference patients, whereas calcium phos-the 67 patients in the None, Small Only, or Bypass groups,
only five had any uric acid in stones, whereas among the phate phases were sparse and uncommon.
66 patients with any colon surgery (Colon Only and
Renal function and stone ratesBoth; Fig. 2A) who also had stone analyses, 32 had some
uric acid in stones (2  49.1, P  0.0001, for variance Male and female bowel patients had lower 24-hour cre-
atinine clearance values than same sex risk factor refer-of uric acid in stones among the 5 groups). The frequency
of uric acid containing stones in the Colon Only group ence patients (Fig. 3A): 121 versus 143 and 164 versus
178 L/24 h, P  0.0025 and 0.0012, bowel disease versuswas higher than in Both patients (2  5.30, P  0.02).
Overall, patients with any colon surgery had a relatively reference, females and males, respectively. By ANOVA,
creatinine clearance differences between bowel patientshigh frequency of uric acid stones compared with those
who had no colon surgery. and risk factor reference patients did not differ signifi-
cantly by sex (P 0.31). There were no variations of cre-As a group, the bowel patients formed stones with a
higher percent uric acid than the reference group (21  atinine clearance between bowel groups by either sex.
Stone rates of bowel patients were above those in the3 vs. 10 1, bowel vs. reference, respectively, P 0.00009).
By ANOVA the Colon Only patients differed from all stone rate reference group (1.54 vs. 1.09, bowel patients
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Fig. 3. (A) Quantile plot of creatinine clear-
ance for women () and men () were below
same sex risk factor reference patients (adja-
cent darker lines). Dashed line intersects dis-
tributions at their median. (B) Quantile plots of
log transformed stone rates for all five bowel
patient groups exceed rates for the stone rate
reference group (dark line). Patients with By-
pass (), Both (), Colon Only (), Small
Only (), and None () did not differ from
each other.
vs. reference group; 95% CI, 1.20-1.96, vs. 1.03-1.18; Fig.
3B). ANOVA with surgical group as the factor and the
log of stone rate as the dependent variable disclosed no
significant differences between groups (P 0.3). Overall,
the bowel disease patients have higher stone rates than
our risk factor reference patients, and reduced 24-hour
creatinine clearance values.
Supersaturation versus type of surgery
If all five groups of bowel disease patients are shown
along the three supersaturation coordinates of calcium
oxalate, calcium phosphate, and uric acid, those with no
surgery reside at one extreme, adjacent to the locale of
the risk factor reference patients, whereas those with
any type of surgery stand elsewhere (Fig. 4). For calcium
oxalate supersaturation, the six groups differ among each
other by ANOVA (P  0.016). Post hoc testing shows
no pair-wise differences except between Small Only ver-
sus risk factor reference patients (P  0.013). For uric
acid supersaturation, the overall ANOVA is significant
Fig. 4. Mean values of supersaturation. Supersaturation for calcium(P 0.000001). Significant pair-wise differences were pres-
oxalate (z axis, height of spike) and supersaturation for calcium phos-
ent, as Figure 4 suggests, between the Colon Only and all phate and uric acid (y and x axes, feet of spike) were similar between
patients with no surgery (None) and the risk factor reference populationother groups except Both (all P  0.01), between Both
(Reference). The other groups differed from the risk factor reference pop-and risk factor reference and None (P 0.001 for both),
ulation (comparisons are in the Results section). Symbols are: () refer-
and between risk factor reference and Small Only (P  ence; () none; () small only; () bypass; () both; () colon only.
0.035). For calcium phosphate supersaturation the over-
all ANOVA was highly significant (P  0.00001); the
pair-wise differences were significant between the risk tients, with or without small bowel surgery, correlated
factor reference patients and Both, Bypass, and Colon well with the enrichment among these patients with uric
Only groups (P  0.0001 for all). acid stones. The low calcium phosphate supersaturation
In summary, we found that with no surgery (None), correlated well with the paucity of calcium phosphate
the stone risk profile seemed rather like that encountered phase in stones from the bowel patients. This offers, once
among the general run of stone formers (risk factor refer- again [19, 23], a strong support for the predictive power
ence patients), whereas any surgery on colon, small bowel, of supersaturation concerning actual stones formed.
or both, shifted the supersaturations generally away from
Determinants of supersaturationcalcium phosphate and toward uric acid, with calcium
oxalate supersaturation remaining reasonably high. The Calcium oxalate. Using general linear modeling, in-
cluding the risk factor reference patients, the main corre-high uric acid supersaturation among colon surgery pa-
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Fig. 5. Factors that determine supersaturation. Quantile plots show the principle factors as determined by multivariate analysis. The risk factor
reference population is shown by the heavy line. Dashed lines intersect with each distribution at its median. Symbols are: Bypass (), Both (),
Colon Only (), Small Only (), None (). All are log transformed except for urine pH and uric acid excretion for display purposes.
lates of calcium oxalate supersaturation were urine vol- ences between groups were significant overall (P 
0.00001 by ANOVA), with specific differences betweenume, calcium excretion, oxalate excretion, and excretions
of sodium and potassium (values of R 2 were 0.215, 0.496, the Both and None groups, and between the risk factor
reference patients and all the groups except the None0.628, 0.686, and 0.696; increments of 0.215, 0.281, 0.132,
0.058, and 0.010, respectively). Given the relative contri- group (Table 2).
Oxalate excretion (Fig. 5, upper right panel) by thebution to increase of R 2, our attention focused on the first
three factors. With the reference population excluded risk factor reference patients was below that of the bowel
patients (39 vs. 53 mg/24 h; P 0.00001). Differences be-(bowel patients only), the results were essentially indis-
tinguishable with respect to the three main factors (0.165, tween groups were significant overall (P  0.00001 for
ANOVA). Bypass exceeded all others, Small Only ex-0.24, 0.191, for calcium, volume, and oxalate increments
in R 2, respectively). ceeded all groups except Bypass and Both, and Both ex-
ceeded Colon Only (Table 2). High oxalate excretionUrine volume (L/24 h) of the bowel disease patients
was lower (Fig. 5, upper left panel) versus the risk factor was therefore important among patients with any small
bowel surgery, but not among those with only colonreference patients (1.44 vs. 1.65; P 0.00014), the excep-
tion being Bypass patients (Table 2). Between the bowel surgery or no surgery.
Uric acid. Using general linear modeling, includingdisease groups (Table 2 and Fig. 5), volume differed by
ANOVA (P  0.00006) with significant differences at the risk factor reference patients, the main urine corre-
lates of uric acid supersaturation were pH, volume, uricpost hoc testing (Table 2) between Colon Only and By-
pass groups and the risk factor reference patients. acid excretion (g/24 h), and sodium (mEq/24 h) excretion
(values of R 2 were 0.636, 0.701, 0.760 and 0.767; incre-Calcium excretion (mg/24 h) by the risk factor refer-
ence patients (Fig. 5, upper middle panel) exceeded that ments were 0.636, 0.065, 0.059 and 0.007, respectively).
Given the relative contribution to increase of R 2 atten-of the bowel patients (221 vs. 144, P  0.00001). Differ-
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Table 2. Selected urine and serum measurements
Type of surgery
Bypass Both Colon only Small only None Reference
Volume mL/24 h 1.880.12 1.410.18 1.220.07a 1.410.11 1.520.1 1.650.02
Calcium mg/24 h 12019 10913 14411 15015 19321b 2212c
Oxalate mg/24 h 10411d 473f 342 575e 423 390.3
pH 5.590.06 5.550.06 5.400.05 5.780.08i 5.980.09h 6.010.01g
Uric acid g/24 h 0.6080.058 0.5510.032 0.5370.023j 0.5610.021 0.6160.036 0.6410.004
Citrate mg/24 h 25460 17532 28529 34262 40253 5216k
Magnesium mg/24 h 617 486 675 595 10111m 1031l
Sodium mEq/24 h 24220n 12215 1108 14911 16812p 1701
Potassium mEq/24 h 554 546 573 482 615 591q
Serum magnesium mg/dL 1.760.03r 1.830.1 1.950.02 1.910.04 2.000.04 2.030.00s
Serum calcium mg/dL 9.110.1t 9.350.1 9.520.05 9.550.1 9.550.1 9.590.01
Values are mean  SEM.
a Differs from Bypass (P  0.003) and Reference (P  0.0004)
b Differs from Both, P  0.036
c Differs from all groups except None, P  0.001
d Differs from all groups, P  0.00001
e Differs from all groups except Both, P  0.002
f Differs from Colon only, P  0.02
g Differs from Bypass, Both, and Small only, P  0.04 and from Colon only, P  0.001
h Differs from Both, and Bypass (P  0.02) and Colon only, P  0.001
i Differs from Colon only, P  0.001
j Differs from Reference, P  0.0015
k Differs from Bypass, Both, Colon only, and Small only, P  0.02
l Differs from Bypass, Both, Colon only, and Small only, P  0.0001
m Differs from Bypass, Both, Colon only, and Small only, P  0.01
n Differs from Both, Colon only, and Small only, P  0.0001, and differs from None and Reference, P  0.001
o Differs from Both and Colon only, P  0.001
p Differs from Colon only, P  0.001
q Differs from Small only, P  0.048
r Differs from all groups but Both, P  0.05
s Differs from all groups, P  0.05
t Differs from Colon only, Small only, None, and Reference, P  0.02
tion was focused on the first three factors. Without refer- [24]. Our bowel patients formed only small amounts of
this phase. The low pH values in their urine, and theirence patients, the conclusions were essentially the same
(values of R 2 were 0.394, 0.615, 0.776 and 0.787; incre- tendency to low urine calcium may well account for such
paucity. Because the phase is not clinically importantments were 0.394, 0.221, 0.161 and 0.011, respectively,
for the same four variables). among stone formers with bowel disease, we do not
choose to burden this text with an extensive analysis of itsUrine pH (Fig. 5, lower left panel) of the risk factor
reference patients exceeded that of all bowel patients supersaturation. However, we have already documented
the calcium excretion, volume levels, and pH values.except for the None group. Differences between groups
were significant overall (P 0.00001 for ANOVA). None
Nutrient related factors that may influenceexceeded Both, Bypass, and Colon Only. As well, Small
stone formationOnly exceeded Colon Only (Table 2). Any bowel surgery
lowered urine pH below that of the risk factor reference Citrate. Citrate is widely recognized as a factor in cal-
cium oxalate stone disease [25] and for this reason it ispatients. In the absence of surgery no difference in pH was
found between patients with bowel disease and those of included in this analysis, even though by multivariate
linear modeling it did not correlate with either calciumthe risk factor reference patients. Colon surgery caused
an especially low urine pH. oxalate or uric acid supersaturation. Our risk factor ref-
erence patients excreted more citrate than the patientsUric acid excretion (Fig. 5, lower middle panel) by
the risk factor reference patients exceeded that of the with bowel disease (Fig. 5, lower right panel; Table 2).
Significant pair-wise differences were present betweenbowel patients overall (P  0.00001). Within specific sub-
group comparisons, Colon Only differed from the risk the risk factor reference patients and all bowel patients
except the None group. Overall, low urine citrate was afactor reference population (Table 2), but no other sub-
groups differed among themselves. clear characteristic of patients who had bowel surgery.
Although citrate was not an independent correlate of
Calcium phosphate calcium oxalate or uric acid supersaturation, low values
may promote stone formation through alternative mech-Urine pH, urine volume, and urine calcium are estab-
lished correlates of calcium phosphate supersaturation anisms [26].
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Fig. 6. Urine and serum nutrient values. Quantile plots show the urine and serum factors that are different from the risk factor reference patients.
Dashed lines intersect with each distribution at its median. Symbols are: Bypass (), Both (), Colon Only (), Small Only (), None ().
Other urine measurements. Urine magnesium binds DISCUSSION
oxalate [27], and could influence calcium oxalate super- Our work confirms some prior findings, but differs in
saturation. The reference factor reference patients and significance because these comparisons are between stone
the None group excreted more magnesium than any of the forming patients with and without bowel disease, whereas
other bowel groups (Fig. 6 and Table 2). Ionic strength past comparisons have been between patients with bowel
was set mainly by urine sodium and potassium, and af- disease, who may or may not have had stones, and normal
fected the divalent activity co-efficient [27], which, in turn, control subjects. Compared to normal subjects, urine vol-
translates a given ion concentration into chemical effec- ume and pH of patients with colon surgery have been re-
tiveness. Bypass patients exceeded all other groups in ported as low [13, 18, 28, 29] and we find the same when
sodium excretion. Potassium excretion differed only be- comparing the bowel patients with colon resection to
tween the Small Only and the risk factor reference pa- common stone formers. Among patients with small bowel
tients (P  0.048; Table 2). resection, we also find low urine pH in comparison to
Serum values. The risk factor reference patients had the risk factor reference patients, but not low volume.
a higher serum magnesium than all of the bowel groups. Bypass patients do not have low volume, although they
The disparity with the None group, however, was insig- do have low urine pH. Altogether, low urine pH is char-
nificant clinically though significant statistically. Bypass acteristic of a wide range of bowel disease patients who
was below all groups except Both. Bypass patients had have had surgery and it is not always associated with low
lower serum calcium values than all groups except the urine volume. On the other hand, absent surgery, low pH
Both group (Table 2). Serum potassium values were lower is not found.
among the bowel patients than the risk factor reference Urine oxalate has been reported as high among pa-
patients (4.08 vs. 4.2, bowel vs. reference, respectively, tients with small bowel resection or bypass as compared
P  0.0004), but there were no differences between the to normal subjects [30–32], and we find it is high com-
pared to common stone formers. Bypass patients havebowel disease groups.
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much more remarkable hyperoxaluria than those with a high general rate of other stone risks such as low citrate,
all conspire to raise the stone recurrence rates. The actualsmall bowel resection. Altogether, what we find among
stone forming patients with bowel disease in comparison mechanisms are not certain at this time. Given their
higher rates and somewhat lower creatinine clearance val-to common stone formers accords well with what has
been found on comparison to normal subjects. We should ues, these patients should be considered at special risk,
and evaluated and treated accordingly.note, however, that the quantitative magnitude of hyper-
oxaluria is quite modest apart from bypass. The relatively low urine calcium levels of all four of our
surgical groups compared to common stone formers, isAs might be presumed if bowel disease caused stones
[5, 9, 33], we found stone disease begins at an appreciable new to this work. Of course, urine calcium levels are low,
here, only in comparison to common stone formers, whointerval after the diagnosis of bowel disease. This inter-
val, though somewhat variable among surgical subgroups, have a high frequency of hypercalciuria [21]. In past
studies, wherein the comparisons have been against nor-ranges between four and seven years. Also, we confirm a
tendency to uric acid stones among patients with colon mal subjects, patients with colon resection had normal
or higher calcium excretions [18, 28, 29], those with smallresection [9, 33], as compared with small bowel resection
or bypass, or in the absence of surgery. Uric acid stones bowel resection or bypass tended to have low urine cal-
cium excretion [18, 32, 37], and those with no surgeryare related to lower urine pH values among colon resec-
tion patients. As well, the lowest urine volumes are found were normocalciuric or hypercalciuric [13, 38]. The main
discrepancy with our findings is that small and large bowelamong patients who have had colon surgery, which adds
to the risk of uric acid stones via increased uric acid resection patients were indistinguishable from each other.
A novel finding here is the striking similarity betweensupersaturation.
The novel finding is that reduced creatinine clearance those patients with bowel disease and no surgery to com-
mon stone formers. As Table 2 and the figures make clear,is a characteristic of bowel disease patients with stones
compared to ordinary stone formers. Of course, renal dis- these two groups virtually cannot be distinguished on
the basis of comprehensive stone risk factors. Even urineease is well described among bypass patients [34, 35],
and among some patients with small bowel disease [36], volume is not significantly lower among the bowel dis-
ease patients than among the common stone patients.but our work shows it is a general characteristic of the
bowel patients. Whether reduced creatinine clearance is Why, then, do they make stones? One answer is that they
simply are stone formers of the common sort, who hap-due only to excessive urine oxalate excretion is not clear,
in that no differences were found among the surgical pen to have a second disease. This is reasonable, but
cannot explain why stones should begin so clearly aftergroups by ANOVA, yet urine oxalate was not high in the
colon resection or non-surgical patients. Possibly, chronic bowel disease. If the two diseases were unrelated, one
would expect the mean difference in age between thelow urine volume adds to the risk of renal damage from
stone crystal formation, a hypothesis that demands work onset of one and the other to be indistinguishable from
zero. This is not the case. Another obvious answer—thatbeyond the present study. We should mention also that
chronic extracellular fluid volume depletion hemody- urine volumes are reduced—is not confirmed by our actual
measurements. One may imagine that medications suchnamically-mediates reduced glomerular filtration chroni-
cally, so that what was measured in our current study as glucocorticoids for bowel disease caused hypercalci-
uria, or that urine volumes have tended to be low in epi-is not necessarily renal damage but merely the renal
response to a contracted fluid volume. This too demands sodes of worsened bowel disease activity. These are spec-
ulations. Of course, it may simply be that the naturaladditional research. Age could be a reason as well, but
our data make this a poor alternative. The mean ages age for bowel disease onset indeed is earlier in life than
that of stones, and among our patients we witness thefor our bowel patients were 47, 46, 42, 45, and 40 years
for colon only, both, small only, bypass, and none, versus enactment of two independent diseases with differing
onset ages.44 years for the reference population. Stones themselves
are not altogether a sufficient cause, in that we find What we can say, with little hesitation, is that in the
absence of surgery the usual pattern of stone-formingcreatinine clearance is low not against normal people
but against stone formers who do not have bowel disease. risk factors is present without significant variation from
that of ordinary patients. Urine oxalate is not increased,Like our patients here, these reference patients have had
their share of stone passage events and procedures, so so one should not expect “enteric hyperoxaluria” given
just bowel disease. Urine calcium levels are not lowerthese sources of renal injury, though perhaps different
in intensity between the groups, is at least partly shared. than among the usual stone formers, who often manifest
hypercalciuria [21]. Measurements of urine crystalliza-Also seemingly new in our current study is a clear
demonstration of higher stone rates among bowel dis- tion inhibition were not done [39], which among both
male and female calcium stone formers is frequently ab-ease patients compared to ordinary stone-forming pa-
tients. We postulate that low volumes, high oxalate, and normal [40, 41]. Perhaps the process of bowel disease af-
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